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Abstract Up to 1% of the human genome is represented by
human endogenous retroviruses (HERVs) and their fragments
that are likely footprints of ancient primate germ-cell infections
by retroviruses that occurred 10^60 million years ago. HERV
solitary long terminal repeats (LTRs) can be often met in close
vicinity to functional genes. The LTRs comprise a set of
regulatory sequences like promoters, enhancers, hormone
responsive elements and polyadenylation signals that might come
out as new regulatory signals to resident genes and thus change
their regulation in evolution. Moreover, the LTRs have a
potential for chromatin remodeling that can also modulate gene
expression. This review describes the integration specificity and
distribution of the HERVs and LTRs in the human genome and
discusses possible functional consequences of their integration in
the vicinity of genes.
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1. Introduction
The great progress in the Human Genome Project opens
prospects of integral vision of the whole genome structural
organization and functional interplay of its elements. In par-
ticular, there is hope that new approaches and techniques will
o¡er a much deeper insight into the role of DNA transposable
elements (TEs) that occupy 35% (!) of the human genome [1].
Until recently the interplay of retroelements and genomes
could be studied for just a few TEs that more or less acciden-
tally came into the view of researchers. Currently more pro-
found though far from comprehensive knowledge is rapidly
accumulating. Even this fragmented information uncovers
many interesting things, allowing one to hypothesize about
a more general picture of the role and function of these ge-
nome argonauts, their ancestry and their involvement in the
genome evolution, regulation, and pathology. In this Minire-
view I am going to focus on one of the TE types, human
endogenous retroviruses (HERV), location of their long ter-
minal repeats (LTRs) in the genome and their possible role in
gene regulation.
2. After-e¡ects of ancient viral infections
Up to 1% of the human genome likely represent footprints
of ancient germ-cell infections by retroviruses [2^6]. The
HERVs and their parts are related to primate and murine
retroviruses and they are the most sophisticated entities
among di¡erent TEs (Fig. 1). Similar to abundant inter-
spersed repeats of Alu or LINE types, the HERVs are retro-
elements that spread throughout genomes by a process termed
retroposition, involving transcription of active element(s) re-
siding in the genome, reverse transcription of the RNA inter-
mediate formed and insertion of the cDNA copy into a new
genomic site. Since the original TE is not eliminated in this
process, retroposition leads to the expansion of the repeats in
the genome.
Various in primary structures and abundance, HERVs are
thought to have been inserted into the germline at di¡erent
times between 6 10 and 60 million years ago [5,6]. Along with
near full-length HERV elements, the HERV superfamily in-
cludes also solitary HERV LTRs with no retroviral genes
attached. As a rule, the number of these solo LTRs is consid-
erably higher than that of their full-length counterparts. For
example, one of the HERV families, HERV-K, comprises as
little as 30^50 near full-size members per haploid genome in
humans, whereas HERV-K-related LTRs have been estimated
to be present in about 10 000^25 000 copies [5].
Some HERVs are transcriptionally active and although ge-
nomes of many HERVs are corrupted by termination codons,
deletions or frame shift mutations, recent studies reveal
HERV protein expression or virus-like particle formation.
HERVs as well as other TEs can be considered as specialized
intragenomic parasites whose jumps over the genome can
cause a multitude of genetic variations, ranging from minor
changes in tissue speci¢city of the gene expression to dramatic
alterations in development (reviewed in [1^11]). The newly
inserted elements mostly cause deleterious e¡ects including
hereditary diseases due to insertional mutations. However,
sometimes the hosts exploit the capacity of TEs to generate
variations for their own bene¢t. The retroelements can come
out as traveling donors of sequence motifs for nucleosome
positioning, DNA methylation, transcriptional enhancers,
poly(A) addition sequences, splice sites, and even amino
acid codons for incorporation into open reading frames of
encoded proteins [8,9].
The number of described cases in which retroelement se-
quences confer useful traits to the host is growing [11^13].
Retropositions can therefore be considered as a major pace-
maker of the evolution that continues to change our genomes
[14^16]. In particular, HERV elements could interact with
human genome through (i) expression of retroviral genes,
(ii) human genome loci rearrangement following the retropo-
sition of the HERVs or (iii) the capacity of LTRs to regulate
nearby genes [2^5]. A plethora of solitary LTRs comprises a
variety of transcription regulatory elements, such as pro-
moters, enhancers, hormone-responsive elements, and poly-
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adenylation signals. Therefore the LTRs are potentially able
to cause signi¢cant changes in expression patterns of neigh-
boring genes.
3. HERV solo LTRs most probably appear due to
recombinational excision of the HERV genomes
The history of TE appearance and ampli¢cation in the
genome is re£ected in particular in the existence of distinct
subgroups within families of related retroelements. The mem-
bers of the subgroups share common structural features and
can be distinguished from those of other subgroups by char-
acteristic (diagnostic) di¡erences in their sequences [17^20].
To explain the existence of the subgroups, in the case of
Alu or LINE repetitive elements it was suggested that the
majority of the members of these families are incapable of
duplicating and only a small number of them, referred to as
master or source genes, is being actively ampli¢ed [17^20].
According to this hypothesis, each subfamily of a retroposon
family is a generation of a speci¢c master gene. New sub-
families are formed when master genes are changed giving
rise to a multitude of mutated master gene(s) copies. The
subfamilies were also described for endogenous retroviruses
HERV-H [21] and their LTRs [22] as well as for HERV-K
[23] and HERV-K LTRs [24,25]. No doubt that more de-
tailed analysis will reveal similar subdivisions for other fam-
ilies of HERVs. It was proposed that LTRs are formed
through retrotransposition of nearly full-size HERVs that
were transcribed, spliced, reverse transcribed, and reinserted
into the genome [5,26,27]. Subsequent homologous recombi-
nations between the LTRs of the newly appeared endogenous
retrovirus result in the deletion of the viral genes and leave
solitary LTRs. There are good examples in favor of such a
mechanism [27,28]. This model implies that the master genes
of LTRs are functional HERVs having potentials for tran-
scription, synthesis of cDNA, containing two fully functional
LTRs and capable of forming functional integration com-
plex. The model looks attractive, however, other mechanisms
implicated in the LTR retroposition should not be ruled out
[5].
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Fig. 1. A: Life cycles of retroviruses and endogenous retroviruses. Stages 1, 2 and 3 are characteristic of retroviruses, other stages are common
for both types of retroelements. The recombination between two LTRs of an endogenous retrovirus leading to the formation of a solo LTR is
depicted. B: Scheme of a HERV-K LTR with positions of putative hormone responsive element (HRE), enhancer, TATA box and polyadeny-
lation signal. The arrow marks the transcription start point.
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4. De novo integration selectivity of TEs: pre-evolutional
opportunities
It would be natural to believe that retroposons randomly
jumped into any site where they could use their integration
machinery, and then the evolution selected the subsets of pri-
mary integrants characteristic of the hosts that did not su¡er
from the invasions or even bene¢ted by them. But lengthy
coexistence of master elements and host genomes could some-
times elaborate more sophisticated TE-genome relations facil-
itating better maintenance of viable TE populations at the
expense of retropositions. Transposons could possibly main-
tain an active form in the host genome for millions of years
due to coadaptation with the genome, diminishing deleterious
e¡ects of fresh integrations by means of speci¢c integration
site choice. Integration targeted at most painless genomic loci
such as non-coding regions, untranslated regions (UTRs), and
introns of genes as well as intergenic space was proposed to be
a widespread strategy adopted by retroelements to successfully
proliferate within the host genome [9,29].
Another way to diminish deleterious changes in the host
genome are the reiterative insertions into or next to pre-exist-
ing retroelements [9]. In such a way the newly inserted TEs
remain phenotypically invisible. The extent of reiterative inte-
gration into pre-existing elements is sometimes very impres-
sive. For example, over 50% of the genome in maize is repre-
sented by retroelements [9]. However, the maize genome was
not knocked out because highly repetitive elements were
mostly targeted at regions between genes and a multitude of
them was nested within other elements [9,30]. In this regard it
is worth mentioning that di¡erent retroelements like Alu or
LTRs may a¡ect nucleosome positioning in the neighboring
regions [31,32]. The nucleosome positioning information is
perhaps intrinsic to these elements and may code the sites of
de novo retroelement integration. For instance, HIV retrovi-
rus frequently integrates directly into or within one nucleo-
some distance from L1H or Alu repetitive elements [33,34].
Another reason for reiterative insertions might be that di¡er-
ent retroelements can consecutively use one and the same
feature of the host chromatin structure [35]. Frequent coinci-
dences of HERVs and their LTRs with Alu and LINE repeats
in human genome were noticed [5,24,28,36], probably re£ect-
ing the bias in their selectivity similar to retroviruses.
The studies of de novo integration speci¢city may help to
better understand the intimate TE-genome interactions.
Although not available for HERVs at this point, the results
for other retroelements demonstrate that transcriptionally ac-
tive genome regions might be preferred targets for retrovirus
integration [37] and that the site selection during retroposition
can be in£uenced by many factors, including transcriptional
status of DNA region, DNA methylation, association of
DNA with histones or other proteins, DNA bending, nucleo-
some positioning, peculiarities of retroelement integration ma-
chinery and its interaction with the host cell factors [33,35,38^
46]. A good example of retroelement^host interaction gives
the study of de novo insertions of Ty1 [47] and Ty3 [48] yeast
retrotransposons that are analogues of endogenous retrovi-
ruses. Most of the integration sites were found clustered up-
stream of the genes transcribed by RNA polymerase III. The
speci¢city of Ty3 integration was shown to be governed by the
interaction of the Ty3 integration complex with some compo-
nents of the RNA-polymerase III transcription machinery.
Ty transposons re£ect important properties of their viral
relatives, striving for transcriptionally active regions to insert
their cDNA copies [37]. This is not surprising considering that
the retroviral genes integrated in the genome need the host
transcriptional machinery to express themselves. But although
this concept of retrovirus selectivity is currently prevailing
[37], practically all genomic regions were reported to be
used as primary integration targets, however, with di¡erent
preferences. There were identi¢ed ‘hot spots’ containing inte-
gration sites used up to 280 times more frequently than pre-
dicted mathematically [41,43]. A recent study of the de novo
retroviral integration demonstrated also preference for scaf-
fold- or matrix-attachment regions (S/MARs) £anked by
DNA with high bending potential [35]. The S/MARs are
thought to be important functional sequences of the genome
that anchor chromatin loops to the nuclear matrix subdividing
the genome into functional domains. They often neighbor
regulatory elements involved in gene expression and DNA
replication.
A cautious generalization from these ¢ndings could be that
although TEs can integrate into many sites and may prefer
non-coding regions, the de novo integration is frequently tar-
geted at the sites in the vicinity of functionally important
elements like transcription start points or origins of replica-
tion.
5. Can the genome somehow mitigate the e¡ects of TEs or are
most mutant germ cells and zygotes doomed to die?
However merciful toward host genomes HERVs may be,
their integration into transcriptionally active loci introduces
extensive and qualitatively new regulatory information capa-
ble of dramatically changing transcription speci¢city. If only a
small proportion of human transposons had a capacity for
retropositions, they would form a huge depot of intragenomic
insertional mutagens. Many TEs can transpose at high rate
when cloned copies are put into host cells [16] and therefore
retain a dangerous potential to the genome integrity. How-
ever, the observed hazardous insertional events seem to be
rather rare: only 1 of 500 new germ line mutations is due
to TE insertions in humans [1]. This low value can be ex-
plained in several not mutually exclusive ways.
1. Newly transposed HERVs can be inactivated by muta-
tions. The value of the mutation rate (reviewed in [49]),
0.13^0.16% per one million years, was accepted by Brit-
ten [50] for mutations in the Alu family of retroelements.
We have estimated the mutation rate in HERV-K LTRs
[25] as 0.26^0.3% and in [22] the rate for HERV-H
LTRs was assumed to be 0.2% per one million years.
It is not known how many mutations are required to kill
the TE ability for retropositions. Nevertheless, the ¢g-
ures above clearly show that the rate of mutation is too
low to quickly destroy dangerous TEs. Therefore some
immediate ¢rst aid to the genome must exist.
2. TE transcription can be repressed. Methylation of CpG
sequences within TEs was suggested to play a major role
in the repression of their expression and therefore retro-
position [1,51,52]. It was reported that 5-methylcytosines
in mammalian DNA mostly reside within TE sequences.
Such an observation even led Yoder et al. [1] to the
hypothesis that suppression of TEs may be the primary
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function of cytosine methylation that evolved in mam-
mals as a host defense mechanism. Indeed, methylation
is known to play a crucial role in the regulation of gene
expression [53], and there are data on suppression of the
transcription of some TEs after methylation [51,52,54].
But here there is a serious inconsistency that can under-
mine the whole idea of the role of methylation in the
host defense against TEs [55]. The methylation status of
TEs during embryo development is contrary to what
should be expected if it was targeted at TE retroposition
repression. DNA is least methylated in germ cells and at
early stages of embryo development, when transcription
of TEs is known to be signi¢cant. Only at some stages of
the postimplantation period become TEs methylated de
novo and their transcription comes down. Therefore it
seems unlikely that methylation can completely prevent
transposition in the germ line where playing with genetic
material is most dangerous for the descendants. Further
research is needed to resolve this problem. On the other
hand, methylation of TEs seems su⁄cient to protect
somatic cells from mutations due to transpositions.
3. The repression can result from low e⁄ciency of posttran-
scriptional stages of retropositions. There are no data
evaluating this e⁄ciency.
4. There could be a mechanism for excision of most newly
inserted TE copies.
5. The simplest explanation is, however, just either ine⁄-
ciency of mature gamete formation from insertionally
mutated germ cells or death of the zygotes formed by
these mutant gametes. This would make the repression
of the transposition or sophisticated processes of ge-
nome repair after the insertion unnecessary.
But in this or other ways the genome has to endure the
invaders. Let us consider the distribution of integration sites
of TEs in genomes that may be pertinent to the problem.
6. Location of the HERV LTRs in genomes: post-evolutional
patterns
I will consider two aspects of the distribution of HERV
LTRs in the genome.
6.1. How are HERV LTRs distributed in genomes if considered
independent of gene location?
The data on physical distribution of di¡erent HERVs and
their LTRs in the human genome are not exhaustive. Neither
preferred chromosomes nor their particular regions were re-
vealed for the integration of RTVL-H2 LTRs and HERV-A
[56], though some clusters of the elements seem to exist on
chromosomes 1p and 7q [57]. 25 000 copies of HERV-K-re-
lated LTRs were reported to be unevenly distributed over
most human chromosomes [5]. A similar uneven distribution
was also reported for HERV-K10 sequences [58]. Preferential
localization of the low-copy number ERV3 related HERV on
Y-chromosome was described [59]. The resources developed
by the Human Genome Project enabled us to precisely map
HERV-K LTRs on human chromosome 19 [25,60]. There was
no correlation between physical neighborhood of the LTRs on
the map and the level of their identity. In most cases the
LTRs with a high level of identity, adjacent on the nearest-
neighbor dendrogram, were located far apart on the chromo-
some, sometimes even on di¡erent chromosome arms. It
means that the LTRs were transposed according to the ‘shot-
gun’ principle, jumping into any region of the chromosome,
rather than by means of a step by step movement along the
chromosome, starting from the point of insertion of a prede-
cessor master LTR. Such random jumping is in contrast to the
transposition manner of some known DNA transposons [61]
that transposed preferentially to nearby chromosomal sites.
Random transpositions into di¡erent chromosome areas
seem to be in con£ict with the above mentioned unbalanced
chromosomal distribution of HERV-K LTRs [5,58]. This con-
tradiction remains to be explained.
6.2. How are HERV LTRs positioned relative to genes?
The complete sequence of the yeast genome was used to
precisely determine positions of the Ty1^Ty5 retrotransposons
with respect to genes [29,62,63]. Generally, the Ty1^Ty4 in-
sertions were found upstream of transcription start sites of
PolIII transcribed genes, whereas Ty5 demonstrated the bias
to origins of DNA replication at the telomers and the silent
mating locus [63]. Since no more than 5^10% of the estimated
total number of human genes is mapped at the chromosome
level, it is presently impossible to comprehensively analyze the
neighborhood of LTRs and the genes. However, some LTRs
and HERVs were shown to be located near or within gene loci
[12,13,36,64^67]. We found frequent coincidences in positions
of HERV-K LTRs and mapped genes on human chromosome
19 [68] where the situation with mapped genes is slightly bet-
ter. Although it would be premature to interpret this result as
the indication of the regulatory interplay between closely lo-
cated LTRs and genes, still some of the coincidences seem
interesting. Most striking is the frequent coincidence of the
LTRs with Zn-¢nger or Zn-¢nger-like genes scattered all over
the chromosome. The implication of retroviral sequences in
expression of Zn-¢nger genes was described [69,70]. The par-
ticipation of retroviral regulatory elements in the expression
of the Zn-¢nger genes could thus be a rather common event.
Recently a new human Zn-¢nger gene was also shown to
contain an endogenous retroviral sequence [36]. Among other
interesting coincidences, the LTRs were often detected in the
vicinity of a number of genes (RRAS, EPOR, JAK3 etc.)
implicated at di¡erent stages of Jak-Stat signal transduction
pathway. The frequent coincidences of the LTRs with the
genes of similar or concerted functions might suggest either
functional involvement of the LTRs in the expression of the
genes or their evolutionary relations.
7. What mechanisms can be used by HERV LTRs in the gene
regulation?
HERV LTRs can modulate the gene expression directly as
transcription regulatory signals or indirectly by means of
chromatin remodeling at the sites of integration.
Possible involvement of HERV LTRs in transcription reg-
ulation of cellular downstream genes has been described
[12,13,69^74]. There were reports on HERV germ line inser-
tions that changed tissue speci¢city of the expression of hu-
man genes [13,73], though this kind of data should be as-
sessed with caution. For example, it was believed that the
integration of an endogenous retrovirus into the 5P-£anking
region of the human amylase gene ensured its expression
additionally in the human salivary gland, apart from the pan-
creas where this gene is normally expressed [73]. But more
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detailed analysis [75] has revealed that the retroelement is not
required for amylase transcription in the primate salivary
gland. However, this example in no way excludes the possi-
bility of a strong direct e¡ect of HERVs on nearby gene
expression.
HERV LTRs might also a¡ect the transcription regulation
through chromatin remodeling as in the case of their relative,
mouse mammary tumor virus (MMTV) promoter. Transcrip-
tionally inactive MMTV LTRs as well as Alu repeat elements
[31] dictate nucleosome phasing [32,76^79] in the way prevent-
ing the access of transcription factors to their cognate sites.
The association of the glucocorticoid receptor with its target
in the LTR bound to core histones leads to nucleosome un-
raveling and transcription. In general, nucleosome positioning
is believed to play an important role in the regulated tran-
scription of eukaryotic genes. The insertion of sequences ca-
pable of locally changing chromatin structure can disturb del-
icate functioning of regulatory factors and a¡ect gene
regulation without direct involvement in the process of tran-
scription. The chromatin structure at the sites of the LTR
integration remains remodeled irrespective of the LTR meth-
ylation status [53,80].
8. Could HERV LTRs in£uence regulation of more than just
neighboring genes?
We do not know how important the involvement of the
LTRs is in genome functioning. What we do know is that
some elements within the LTRs are highly conserved in evo-
lution [25]. These include in particular TATA box, polyade-
nylation signal, borders between the R and U3 and U5 re-
gions. There probably exists a kind of selection protecting the
elements from mutational erosion. Similar conservatism was
also observed for Alu repeats [17]. It supports the idea that the
LTRs (and perhaps other TEs) are of importance for some
genomic purposes. At the present stage of our knowledge we
can only guess what these purposes are, but they can probably
extend beyond just regulation of particular genes. In this con-
nection let us remember the frequent location of the LTRs in
the vicinity of Zn-¢nger genes. Many Zn-¢nger proteins func-
tion as transcriptional regulators, so changes in their own
regulation can have an impact upon expression of multitudes
of other genes. In this way e¡ects of the LTRs on regulatory
genes might be of importance for the whole genome. Similar
global e¡ects of the LTRs can be expected in the case of genes
involved in the regulation of cell life, such as signal trans-
duction exempli¢ed above by Jak-Stat pathway.
9. Conclusion
The limited information available at present does not allow
us to answer most of the questions put in this review. The
whole human genome sequenced and compared to the ge-
nomes of other mammals will hopefully tell us the history
of the genome invasion by HERVs and LTRs and their sub-
sequent migration, in exactly the same way as, for example,
DNA analysis of various human populations uncovered time
and place of habitat of ‘mitochondrial Eva’ and ‘Adam’ and
migration of their descendants all over the earth. And perhaps
we will learn about the tragic viral epidemics that struck our
ancestors and forever changed their destinies having given rise
to Homo sapiens lineage in evolution.
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